A significant inhibitory phenotype on tumour growth was also observed when host ATF4 was excised following the establishment of palpable B16F10 tumours, which provides further support for the role of ATF4 as a potential therapeutic target (Fig. 1f). This evidence concerns the gene ATF4 and neoplasm.